Comparison of two growth hormone stimulation tests and their cut-off limits in healthy adults at an outpatient clinic

A peak GH less than 3μg/L to insulin tolerance test (ITT) is commonly used as a threshold indicating severe adult GH deficiency (GHD). This cut-off is based on results obtained by polyclonal radioimmunoassays preferably under standard conditions at hospital. Our aim was to evaluate the validity of t...
Ausführliche Beschreibung

Gespeichert in:

Autor*in:	Markkanen, Helene M. [verfasserIn] Pekkarinen, Tuula Välimäki, Matti J. Alfthan, Henrik Hämäläinen, Esa Stenman, Ulf-Håkan

Format:	E-Artikel
Sprache:	Englisch

Erschienen:	2013

Umfang:	5

Übergeordnetes Werk:	Enthalten in: Research on Origins of Type 1 Diabetes Seeks Organ Donor Referrals From the ED - 2012, Burlington, Mass. [u.a.]
Übergeordnetes Werk:	volume:23 ; year:2013 ; number:5 ; pages:165-169 ; extent:5

Links:	Volltext

DOI / URN:	10.1016/j.ghir.2013.06.002

Katalog-ID:	ELV033413770

Internformat


LEADER	01000caa a22002652 4500
001	ELV033413770
003	DE-627
005	20230623225735.0
007	cr uuu---uuuuu
008	180603s2013 xx \|\|\|\|\|o 00\| \|\|eng c
024	7		\|a 10.1016/j.ghir.2013.06.002 \|2 doi
028	5	2	\|a GBVA2013018000017.pica
035			\|a (DE-627)ELV033413770
035			\|a (ELSEVIER)S1096-6374(13)00061-0
040			\|a DE-627 \|b ger \|c DE-627 \|e rakwb
041			\|a eng
082	0		\|a 610 \|a 570
082	0	4	\|a 610 \|q DE-600
082	0	4	\|a 570 \|q DE-600
082	0	4	\|a 610 \|q VZ
082	0	4	\|a 530 \|q VZ
084			\|a 43.13 \|2 bkl
084			\|a 50.17 \|2 bkl
084			\|a 58.53 \|2 bkl
100	1		\|a Markkanen, Helene M. \|e verfasserin \|4 aut
245	1	0	\|a Comparison of two growth hormone stimulation tests and their cut-off limits in healthy adults at an outpatient clinic
264		1	\|c 2013
300			\|a 5
336			\|a nicht spezifiziert \|b zzz \|2 rdacontent
337			\|a nicht spezifiziert \|b z \|2 rdamedia
338			\|a nicht spezifiziert \|b zu \|2 rdacarrier
520			\|a A peak GH less than 3μg/L to insulin tolerance test (ITT) is commonly used as a threshold indicating severe adult GH deficiency (GHD). This cut-off is based on results obtained by polyclonal radioimmunoassays preferably under standard conditions at hospital. Our aim was to evaluate the validity of this cut-off limit using two currently used immunometric GH assays and to compare GH responses in the ITT and the GH releasing hormone+arginine (GHRH+ARG) test in healthy adults at our outpatient endocrine unit.
700	1		\|a Pekkarinen, Tuula \|4 oth
700	1		\|a Välimäki, Matti J. \|4 oth
700	1		\|a Alfthan, Henrik \|4 oth
700	1		\|a Hämäläinen, Esa \|4 oth
700	1		\|a Stenman, Ulf-Håkan \|4 oth
773	0	8	\|i Enthalten in \|n Harcourt \|t Research on Origins of Type 1 Diabetes Seeks Organ Donor Referrals From the ED \|d 2012 \|g Burlington, Mass. [u.a.] \|w (DE-627)ELV02124619X
773	1	8	\|g volume:23 \|g year:2013 \|g number:5 \|g pages:165-169 \|g extent:5
856	4	0	\|u https://doi.org/10.1016/j.ghir.2013.06.002 \|3 Volltext
912			\|a GBV_USEFLAG_U
912			\|a GBV_ELV
912			\|a SYSFLAG_U
912			\|a SSG-OPC-GGO
912			\|a GBV_ILN_20
912			\|a GBV_ILN_21
912			\|a GBV_ILN_22
912			\|a GBV_ILN_23
912			\|a GBV_ILN_24
912			\|a GBV_ILN_30
912			\|a GBV_ILN_31
912			\|a GBV_ILN_32
912			\|a GBV_ILN_40
912			\|a GBV_ILN_55
912			\|a GBV_ILN_60
912			\|a GBV_ILN_65
912			\|a GBV_ILN_69
912			\|a GBV_ILN_70
912			\|a GBV_ILN_74
912			\|a GBV_ILN_90
912			\|a GBV_ILN_100
912			\|a GBV_ILN_105
912			\|a GBV_ILN_120
912			\|a GBV_ILN_130
912			\|a GBV_ILN_131
912			\|a GBV_ILN_170
912			\|a GBV_ILN_2001
912			\|a GBV_ILN_2002
912			\|a GBV_ILN_2003
912			\|a GBV_ILN_2004
912			\|a GBV_ILN_2005
912			\|a GBV_ILN_2006
912			\|a GBV_ILN_2009
912			\|a GBV_ILN_2010
912			\|a GBV_ILN_2012
912			\|a GBV_ILN_2014
912			\|a GBV_ILN_2015
912			\|a GBV_ILN_2021
912			\|a GBV_ILN_2047
912			\|a GBV_ILN_2050
912			\|a GBV_ILN_2111
912			\|a GBV_ILN_2149
936	b	k	\|a 43.13 \|j Umwelttoxikologie \|q VZ
936	b	k	\|a 50.17 \|j Sicherheitstechnik \|q VZ
936	b	k	\|a 58.53 \|j Abfallwirtschaft \|q VZ
951			\|a AR
952			\|d 23 \|j 2013 \|e 5 \|h 165-169 \|g 5
953			\|2 045F \|a 610

Indexfelder

author_variant	h m m hm hmm
matchkey_str	markkanenhelenempekkarinentuulavlimkimat:2013----:oprsnfwgothroetmltotssnteruofiisnelh
hierarchy_sort_str	2013
bklnumber	43.13 50.17 58.53
publishDate	2013
allfields	10.1016/j.ghir.2013.06.002 doi GBVA2013018000017.pica (DE-627)ELV033413770 (ELSEVIER)S1096-6374(13)00061-0 DE-627 ger DE-627 rakwb eng 610 570 610 DE-600 570 DE-600 610 VZ 530 VZ 43.13 bkl 50.17 bkl 58.53 bkl Markkanen, Helene M. verfasserin aut Comparison of two growth hormone stimulation tests and their cut-off limits in healthy adults at an outpatient clinic 2013 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier A peak GH less than 3μg/L to insulin tolerance test (ITT) is commonly used as a threshold indicating severe adult GH deficiency (GHD). This cut-off is based on results obtained by polyclonal radioimmunoassays preferably under standard conditions at hospital. Our aim was to evaluate the validity of this cut-off limit using two currently used immunometric GH assays and to compare GH responses in the ITT and the GH releasing hormone+arginine (GHRH+ARG) test in healthy adults at our outpatient endocrine unit. Pekkarinen, Tuula oth Välimäki, Matti J. oth Alfthan, Henrik oth Hämäläinen, Esa oth Stenman, Ulf-Håkan oth Enthalten in Harcourt Research on Origins of Type 1 Diabetes Seeks Organ Donor Referrals From the ED 2012 Burlington, Mass. [u.a.] (DE-627)ELV02124619X volume:23 year:2013 number:5 pages:165-169 extent:5 https://doi.org/10.1016/j.ghir.2013.06.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GGO GBV_ILN_20 GBV_ILN_21 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_30 GBV_ILN_31 GBV_ILN_32 GBV_ILN_40 GBV_ILN_55 GBV_ILN_60 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_74 GBV_ILN_90 GBV_ILN_100 GBV_ILN_105 GBV_ILN_120 GBV_ILN_130 GBV_ILN_131 GBV_ILN_170 GBV_ILN_2001 GBV_ILN_2002 GBV_ILN_2003 GBV_ILN_2004 GBV_ILN_2005 GBV_ILN_2006 GBV_ILN_2009 GBV_ILN_2010 GBV_ILN_2012 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2021 GBV_ILN_2047 GBV_ILN_2050 GBV_ILN_2111 GBV_ILN_2149 43.13 Umwelttoxikologie VZ 50.17 Sicherheitstechnik VZ 58.53 Abfallwirtschaft VZ AR 23 2013 5 165-169 5 045F 610
spelling	10.1016/j.ghir.2013.06.002 doi GBVA2013018000017.pica (DE-627)ELV033413770 (ELSEVIER)S1096-6374(13)00061-0 DE-627 ger DE-627 rakwb eng 610 570 610 DE-600 570 DE-600 610 VZ 530 VZ 43.13 bkl 50.17 bkl 58.53 bkl Markkanen, Helene M. verfasserin aut Comparison of two growth hormone stimulation tests and their cut-off limits in healthy adults at an outpatient clinic 2013 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier A peak GH less than 3μg/L to insulin tolerance test (ITT) is commonly used as a threshold indicating severe adult GH deficiency (GHD). This cut-off is based on results obtained by polyclonal radioimmunoassays preferably under standard conditions at hospital. Our aim was to evaluate the validity of this cut-off limit using two currently used immunometric GH assays and to compare GH responses in the ITT and the GH releasing hormone+arginine (GHRH+ARG) test in healthy adults at our outpatient endocrine unit. Pekkarinen, Tuula oth Välimäki, Matti J. oth Alfthan, Henrik oth Hämäläinen, Esa oth Stenman, Ulf-Håkan oth Enthalten in Harcourt Research on Origins of Type 1 Diabetes Seeks Organ Donor Referrals From the ED 2012 Burlington, Mass. [u.a.] (DE-627)ELV02124619X volume:23 year:2013 number:5 pages:165-169 extent:5 https://doi.org/10.1016/j.ghir.2013.06.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GGO GBV_ILN_20 GBV_ILN_21 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_30 GBV_ILN_31 GBV_ILN_32 GBV_ILN_40 GBV_ILN_55 GBV_ILN_60 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_74 GBV_ILN_90 GBV_ILN_100 GBV_ILN_105 GBV_ILN_120 GBV_ILN_130 GBV_ILN_131 GBV_ILN_170 GBV_ILN_2001 GBV_ILN_2002 GBV_ILN_2003 GBV_ILN_2004 GBV_ILN_2005 GBV_ILN_2006 GBV_ILN_2009 GBV_ILN_2010 GBV_ILN_2012 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2021 GBV_ILN_2047 GBV_ILN_2050 GBV_ILN_2111 GBV_ILN_2149 43.13 Umwelttoxikologie VZ 50.17 Sicherheitstechnik VZ 58.53 Abfallwirtschaft VZ AR 23 2013 5 165-169 5 045F 610
allfields_unstemmed	10.1016/j.ghir.2013.06.002 doi GBVA2013018000017.pica (DE-627)ELV033413770 (ELSEVIER)S1096-6374(13)00061-0 DE-627 ger DE-627 rakwb eng 610 570 610 DE-600 570 DE-600 610 VZ 530 VZ 43.13 bkl 50.17 bkl 58.53 bkl Markkanen, Helene M. verfasserin aut Comparison of two growth hormone stimulation tests and their cut-off limits in healthy adults at an outpatient clinic 2013 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier A peak GH less than 3μg/L to insulin tolerance test (ITT) is commonly used as a threshold indicating severe adult GH deficiency (GHD). This cut-off is based on results obtained by polyclonal radioimmunoassays preferably under standard conditions at hospital. Our aim was to evaluate the validity of this cut-off limit using two currently used immunometric GH assays and to compare GH responses in the ITT and the GH releasing hormone+arginine (GHRH+ARG) test in healthy adults at our outpatient endocrine unit. Pekkarinen, Tuula oth Välimäki, Matti J. oth Alfthan, Henrik oth Hämäläinen, Esa oth Stenman, Ulf-Håkan oth Enthalten in Harcourt Research on Origins of Type 1 Diabetes Seeks Organ Donor Referrals From the ED 2012 Burlington, Mass. [u.a.] (DE-627)ELV02124619X volume:23 year:2013 number:5 pages:165-169 extent:5 https://doi.org/10.1016/j.ghir.2013.06.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GGO GBV_ILN_20 GBV_ILN_21 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_30 GBV_ILN_31 GBV_ILN_32 GBV_ILN_40 GBV_ILN_55 GBV_ILN_60 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_74 GBV_ILN_90 GBV_ILN_100 GBV_ILN_105 GBV_ILN_120 GBV_ILN_130 GBV_ILN_131 GBV_ILN_170 GBV_ILN_2001 GBV_ILN_2002 GBV_ILN_2003 GBV_ILN_2004 GBV_ILN_2005 GBV_ILN_2006 GBV_ILN_2009 GBV_ILN_2010 GBV_ILN_2012 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2021 GBV_ILN_2047 GBV_ILN_2050 GBV_ILN_2111 GBV_ILN_2149 43.13 Umwelttoxikologie VZ 50.17 Sicherheitstechnik VZ 58.53 Abfallwirtschaft VZ AR 23 2013 5 165-169 5 045F 610
allfieldsGer	10.1016/j.ghir.2013.06.002 doi GBVA2013018000017.pica (DE-627)ELV033413770 (ELSEVIER)S1096-6374(13)00061-0 DE-627 ger DE-627 rakwb eng 610 570 610 DE-600 570 DE-600 610 VZ 530 VZ 43.13 bkl 50.17 bkl 58.53 bkl Markkanen, Helene M. verfasserin aut Comparison of two growth hormone stimulation tests and their cut-off limits in healthy adults at an outpatient clinic 2013 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier A peak GH less than 3μg/L to insulin tolerance test (ITT) is commonly used as a threshold indicating severe adult GH deficiency (GHD). This cut-off is based on results obtained by polyclonal radioimmunoassays preferably under standard conditions at hospital. Our aim was to evaluate the validity of this cut-off limit using two currently used immunometric GH assays and to compare GH responses in the ITT and the GH releasing hormone+arginine (GHRH+ARG) test in healthy adults at our outpatient endocrine unit. Pekkarinen, Tuula oth Välimäki, Matti J. oth Alfthan, Henrik oth Hämäläinen, Esa oth Stenman, Ulf-Håkan oth Enthalten in Harcourt Research on Origins of Type 1 Diabetes Seeks Organ Donor Referrals From the ED 2012 Burlington, Mass. [u.a.] (DE-627)ELV02124619X volume:23 year:2013 number:5 pages:165-169 extent:5 https://doi.org/10.1016/j.ghir.2013.06.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GGO GBV_ILN_20 GBV_ILN_21 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_30 GBV_ILN_31 GBV_ILN_32 GBV_ILN_40 GBV_ILN_55 GBV_ILN_60 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_74 GBV_ILN_90 GBV_ILN_100 GBV_ILN_105 GBV_ILN_120 GBV_ILN_130 GBV_ILN_131 GBV_ILN_170 GBV_ILN_2001 GBV_ILN_2002 GBV_ILN_2003 GBV_ILN_2004 GBV_ILN_2005 GBV_ILN_2006 GBV_ILN_2009 GBV_ILN_2010 GBV_ILN_2012 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2021 GBV_ILN_2047 GBV_ILN_2050 GBV_ILN_2111 GBV_ILN_2149 43.13 Umwelttoxikologie VZ 50.17 Sicherheitstechnik VZ 58.53 Abfallwirtschaft VZ AR 23 2013 5 165-169 5 045F 610
allfieldsSound	10.1016/j.ghir.2013.06.002 doi GBVA2013018000017.pica (DE-627)ELV033413770 (ELSEVIER)S1096-6374(13)00061-0 DE-627 ger DE-627 rakwb eng 610 570 610 DE-600 570 DE-600 610 VZ 530 VZ 43.13 bkl 50.17 bkl 58.53 bkl Markkanen, Helene M. verfasserin aut Comparison of two growth hormone stimulation tests and their cut-off limits in healthy adults at an outpatient clinic 2013 5 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier A peak GH less than 3μg/L to insulin tolerance test (ITT) is commonly used as a threshold indicating severe adult GH deficiency (GHD). This cut-off is based on results obtained by polyclonal radioimmunoassays preferably under standard conditions at hospital. Our aim was to evaluate the validity of this cut-off limit using two currently used immunometric GH assays and to compare GH responses in the ITT and the GH releasing hormone+arginine (GHRH+ARG) test in healthy adults at our outpatient endocrine unit. Pekkarinen, Tuula oth Välimäki, Matti J. oth Alfthan, Henrik oth Hämäläinen, Esa oth Stenman, Ulf-Håkan oth Enthalten in Harcourt Research on Origins of Type 1 Diabetes Seeks Organ Donor Referrals From the ED 2012 Burlington, Mass. [u.a.] (DE-627)ELV02124619X volume:23 year:2013 number:5 pages:165-169 extent:5 https://doi.org/10.1016/j.ghir.2013.06.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GGO GBV_ILN_20 GBV_ILN_21 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_30 GBV_ILN_31 GBV_ILN_32 GBV_ILN_40 GBV_ILN_55 GBV_ILN_60 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_74 GBV_ILN_90 GBV_ILN_100 GBV_ILN_105 GBV_ILN_120 GBV_ILN_130 GBV_ILN_131 GBV_ILN_170 GBV_ILN_2001 GBV_ILN_2002 GBV_ILN_2003 GBV_ILN_2004 GBV_ILN_2005 GBV_ILN_2006 GBV_ILN_2009 GBV_ILN_2010 GBV_ILN_2012 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2021 GBV_ILN_2047 GBV_ILN_2050 GBV_ILN_2111 GBV_ILN_2149 43.13 Umwelttoxikologie VZ 50.17 Sicherheitstechnik VZ 58.53 Abfallwirtschaft VZ AR 23 2013 5 165-169 5 045F 610
language	English
source	Enthalten in Research on Origins of Type 1 Diabetes Seeks Organ Donor Referrals From the ED Burlington, Mass. [u.a.] volume:23 year:2013 number:5 pages:165-169 extent:5
sourceStr	Enthalten in Research on Origins of Type 1 Diabetes Seeks Organ Donor Referrals From the ED Burlington, Mass. [u.a.] volume:23 year:2013 number:5 pages:165-169 extent:5
format_phy_str_mv	Article
bklname	Umwelttoxikologie Sicherheitstechnik Abfallwirtschaft
institution	findex.gbv.de
dewey-raw	610
isfreeaccess_bool	false
container_title	Research on Origins of Type 1 Diabetes Seeks Organ Donor Referrals From the ED
authorswithroles_txt_mv	Markkanen, Helene M. @@aut@@ Pekkarinen, Tuula @@oth@@ Välimäki, Matti J. @@oth@@ Alfthan, Henrik @@oth@@ Hämäläinen, Esa @@oth@@ Stenman, Ulf-Håkan @@oth@@
publishDateDaySort_date	2013-01-01T00:00:00Z
hierarchy_top_id	ELV02124619X
dewey-sort	3610
id	ELV033413770
language_de	englisch
fullrecord	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV033413770</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623225735.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2013 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ghir.2013.06.002</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2013018000017.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV033413770</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1096-6374(13)00061-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield><subfield code="a">570</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">530</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">43.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">50.17</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">58.53</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Markkanen, Helene M.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Comparison of two growth hormone stimulation tests and their cut-off limits in healthy adults at an outpatient clinic</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">A peak GH less than 3μg/L to insulin tolerance test (ITT) is commonly used as a threshold indicating severe adult GH deficiency (GHD). This cut-off is based on results obtained by polyclonal radioimmunoassays preferably under standard conditions at hospital. Our aim was to evaluate the validity of this cut-off limit using two currently used immunometric GH assays and to compare GH responses in the ITT and the GH releasing hormone+arginine (GHRH+ARG) test in healthy adults at our outpatient endocrine unit.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pekkarinen, Tuula</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Välimäki, Matti J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Alfthan, Henrik</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hämäläinen, Esa</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Stenman, Ulf-Håkan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Harcourt</subfield><subfield code="t">Research on Origins of Type 1 Diabetes Seeks Organ Donor Referrals From the ED</subfield><subfield code="d">2012</subfield><subfield code="g">Burlington, Mass. [u.a.]</subfield><subfield code="w">(DE-627)ELV02124619X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:23</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:5</subfield><subfield code="g">pages:165-169</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ghir.2013.06.002</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-GGO</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_21</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_30</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_32</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_55</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_90</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_100</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_120</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_130</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_131</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2001</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2002</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2004</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2006</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2010</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2015</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2021</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2047</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2050</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2149</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">43.13</subfield><subfield code="j">Umwelttoxikologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">50.17</subfield><subfield code="j">Sicherheitstechnik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">58.53</subfield><subfield code="j">Abfallwirtschaft</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">23</subfield><subfield code="j">2013</subfield><subfield code="e">5</subfield><subfield code="h">165-169</subfield><subfield code="g">5</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
author	Markkanen, Helene M.
spellingShingle	Markkanen, Helene M. ddc 610 ddc 570 ddc 530 bkl 43.13 bkl 50.17 bkl 58.53 Comparison of two growth hormone stimulation tests and their cut-off limits in healthy adults at an outpatient clinic
authorStr	Markkanen, Helene M.
ppnlink_with_tag_str_mv	@@773@@(DE-627)ELV02124619X
format	electronic Article
dewey-ones	610 - Medicine & health 570 - Life sciences; biology 530 - Physics
delete_txt_mv	keep
author_role	aut
collection	elsevier
remote_str	true
illustrated	Not Illustrated
topic_title	610 570 610 DE-600 570 DE-600 610 VZ 530 VZ 43.13 bkl 50.17 bkl 58.53 bkl Comparison of two growth hormone stimulation tests and their cut-off limits in healthy adults at an outpatient clinic
topic	ddc 610 ddc 570 ddc 530 bkl 43.13 bkl 50.17 bkl 58.53
topic_unstemmed	ddc 610 ddc 570 ddc 530 bkl 43.13 bkl 50.17 bkl 58.53
topic_browse	ddc 610 ddc 570 ddc 530 bkl 43.13 bkl 50.17 bkl 58.53
format_facet	Elektronische Aufsätze Aufsätze Elektronische Ressource
format_main_str_mv	Text Zeitschrift/Artikel
carriertype_str_mv	zu
author2_variant	t p tp m j v mj mjv h a ha e h eh u h s uhs
hierarchy_parent_title	Research on Origins of Type 1 Diabetes Seeks Organ Donor Referrals From the ED
hierarchy_parent_id	ELV02124619X
dewey-tens	610 - Medicine & health 570 - Life sciences; biology 530 - Physics
hierarchy_top_title	Research on Origins of Type 1 Diabetes Seeks Organ Donor Referrals From the ED
isfreeaccess_txt	false
familylinks_str_mv	(DE-627)ELV02124619X
title	Comparison of two growth hormone stimulation tests and their cut-off limits in healthy adults at an outpatient clinic
ctrlnum	(DE-627)ELV033413770 (ELSEVIER)S1096-6374(13)00061-0
title_full	Comparison of two growth hormone stimulation tests and their cut-off limits in healthy adults at an outpatient clinic
author_sort	Markkanen, Helene M.
journal	Research on Origins of Type 1 Diabetes Seeks Organ Donor Referrals From the ED
journalStr	Research on Origins of Type 1 Diabetes Seeks Organ Donor Referrals From the ED
lang_code	eng
isOA_bool	false
dewey-hundreds	600 - Technology 500 - Science
recordtype	marc
publishDateSort	2013
contenttype_str_mv	zzz
container_start_page	165
author_browse	Markkanen, Helene M.
container_volume	23
physical	5
class	610 570 610 DE-600 570 DE-600 610 VZ 530 VZ 43.13 bkl 50.17 bkl 58.53 bkl
format_se	Elektronische Aufsätze
author-letter	Markkanen, Helene M.
doi_str_mv	10.1016/j.ghir.2013.06.002
dewey-full	610 570 530
title_sort	comparison of two growth hormone stimulation tests and their cut-off limits in healthy adults at an outpatient clinic
title_auth	Comparison of two growth hormone stimulation tests and their cut-off limits in healthy adults at an outpatient clinic
abstract	A peak GH less than 3μg/L to insulin tolerance test (ITT) is commonly used as a threshold indicating severe adult GH deficiency (GHD). This cut-off is based on results obtained by polyclonal radioimmunoassays preferably under standard conditions at hospital. Our aim was to evaluate the validity of this cut-off limit using two currently used immunometric GH assays and to compare GH responses in the ITT and the GH releasing hormone+arginine (GHRH+ARG) test in healthy adults at our outpatient endocrine unit.
abstractGer	A peak GH less than 3μg/L to insulin tolerance test (ITT) is commonly used as a threshold indicating severe adult GH deficiency (GHD). This cut-off is based on results obtained by polyclonal radioimmunoassays preferably under standard conditions at hospital. Our aim was to evaluate the validity of this cut-off limit using two currently used immunometric GH assays and to compare GH responses in the ITT and the GH releasing hormone+arginine (GHRH+ARG) test in healthy adults at our outpatient endocrine unit.
abstract_unstemmed	A peak GH less than 3μg/L to insulin tolerance test (ITT) is commonly used as a threshold indicating severe adult GH deficiency (GHD). This cut-off is based on results obtained by polyclonal radioimmunoassays preferably under standard conditions at hospital. Our aim was to evaluate the validity of this cut-off limit using two currently used immunometric GH assays and to compare GH responses in the ITT and the GH releasing hormone+arginine (GHRH+ARG) test in healthy adults at our outpatient endocrine unit.
collection_details	GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OPC-GGO GBV_ILN_20 GBV_ILN_21 GBV_ILN_22 GBV_ILN_23 GBV_ILN_24 GBV_ILN_30 GBV_ILN_31 GBV_ILN_32 GBV_ILN_40 GBV_ILN_55 GBV_ILN_60 GBV_ILN_65 GBV_ILN_69 GBV_ILN_70 GBV_ILN_74 GBV_ILN_90 GBV_ILN_100 GBV_ILN_105 GBV_ILN_120 GBV_ILN_130 GBV_ILN_131 GBV_ILN_170 GBV_ILN_2001 GBV_ILN_2002 GBV_ILN_2003 GBV_ILN_2004 GBV_ILN_2005 GBV_ILN_2006 GBV_ILN_2009 GBV_ILN_2010 GBV_ILN_2012 GBV_ILN_2014 GBV_ILN_2015 GBV_ILN_2021 GBV_ILN_2047 GBV_ILN_2050 GBV_ILN_2111 GBV_ILN_2149
container_issue	5
title_short	Comparison of two growth hormone stimulation tests and their cut-off limits in healthy adults at an outpatient clinic
url	https://doi.org/10.1016/j.ghir.2013.06.002
remote_bool	true
author2	Pekkarinen, Tuula Välimäki, Matti J. Alfthan, Henrik Hämäläinen, Esa Stenman, Ulf-Håkan
author2Str	Pekkarinen, Tuula Välimäki, Matti J. Alfthan, Henrik Hämäläinen, Esa Stenman, Ulf-Håkan
ppnlink	ELV02124619X
mediatype_str_mv	z
isOA_txt	false
hochschulschrift_bool	false
author2_role	oth oth oth oth oth
doi_str	10.1016/j.ghir.2013.06.002
up_date	2024-07-06T18:30:48.705Z
_version_	1803855487258591232
fullrecord_marcxml	<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV033413770</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230623225735.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2013 xx \|\|\|\|\|o 00\| \|\|eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.ghir.2013.06.002</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2013018000017.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV033413770</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S1096-6374(13)00061-0</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield><subfield code="a">570</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">570</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">530</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">43.13</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">50.17</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">58.53</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Markkanen, Helene M.</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Comparison of two growth hormone stimulation tests and their cut-off limits in healthy adults at an outpatient clinic</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2013</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">5</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">A peak GH less than 3μg/L to insulin tolerance test (ITT) is commonly used as a threshold indicating severe adult GH deficiency (GHD). This cut-off is based on results obtained by polyclonal radioimmunoassays preferably under standard conditions at hospital. Our aim was to evaluate the validity of this cut-off limit using two currently used immunometric GH assays and to compare GH responses in the ITT and the GH releasing hormone+arginine (GHRH+ARG) test in healthy adults at our outpatient endocrine unit.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Pekkarinen, Tuula</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Välimäki, Matti J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Alfthan, Henrik</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hämäläinen, Esa</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Stenman, Ulf-Håkan</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Harcourt</subfield><subfield code="t">Research on Origins of Type 1 Diabetes Seeks Organ Donor Referrals From the ED</subfield><subfield code="d">2012</subfield><subfield code="g">Burlington, Mass. [u.a.]</subfield><subfield code="w">(DE-627)ELV02124619X</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:23</subfield><subfield code="g">year:2013</subfield><subfield code="g">number:5</subfield><subfield code="g">pages:165-169</subfield><subfield code="g">extent:5</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.ghir.2013.06.002</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OPC-GGO</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_20</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_21</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_23</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_24</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_30</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_31</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_32</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_55</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_60</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_65</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_69</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_70</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_74</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_90</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_100</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_105</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_120</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_130</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_131</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_170</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2001</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2002</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2003</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2004</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2005</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2006</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2009</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2010</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2012</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2014</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2015</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2021</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2047</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2050</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2111</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_2149</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">43.13</subfield><subfield code="j">Umwelttoxikologie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">50.17</subfield><subfield code="j">Sicherheitstechnik</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">58.53</subfield><subfield code="j">Abfallwirtschaft</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">23</subfield><subfield code="j">2013</subfield><subfield code="e">5</subfield><subfield code="h">165-169</subfield><subfield code="g">5</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
score	7.3991175

Nicht das Richtige dabei?

Schreiben Sie uns!

Comparison of two growth hormone stimulation tests and their cut-off limits in healthy adults at an outpatient clinic

Nicht das Richtige dabei?

Zugang & Verfügbarkeit

Vorhandene Bände

Nicht das Richtige dabei?